Gross Profit On Sales Veränderung Datum
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Cara Therapeutics USD 3.31M 2.21M 2023-09
Corcept Therapeutics USD 121.96M 5.82M 2023-09
Eisai JPY 140.19B 12.82B 2023-09
Eli Lilly USD 7.57B 73.1M 2023-12
Incyte USD 949.29M 84.66M 2023-12
Intra Cellular Therapies USD 121.4M 4.35M 2023-12
J&J USD 14.6B 374M 2023-12
Marinus Pharmaceuticals USD 6.88M 1.19M 2023-09
Moderna USD 1.88B 2.29B 2023-12
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
PTC Therapeutics USD 277.94M 90.85M 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
Vanda Pharmaceuticals USD 42.56M 15.17M 2023-06
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Acadia Pharmaceuticals Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.